10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
AMGEN INC | ||
Ticker: AMGN Fiscal Year: 2021 | ||
Consolidated Balance Sheets | ||
Period Ending Dec 31, 2021 10-K (Filed: Feb 16, 2022) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2021 | Dec 31, 2020 | |
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 7,989 | 6,266 |
Marketable securities | 48 | 4,381 |
Trade receivables, net | 4,895 | 4,525 |
Inventories | 4,086 | 3,893 |
Other current assets | 2,367 | 2,079 |
Total current assets | 19,385 | 21,144 |
Property, plant and equipment, net | 5,184 | 4,889 |
Intangible assets, net | 15,182 | 16,587 |
Goodwill | 14,890 | 14,689 |
Other noncurrent assets | 6,524 | 5,639 |
Total assets | 61,165 | 62,948 |
LIABILITIES AND STOCKHOLDERS EQUITY | ||
Current liabilities: | ||
Accounts payable | 1,366 | 1,421 |
Accrued liabilities | 10,731 | 10,141 |
Current portion of long-term debt | 87 | 91 |
Total current liabilities | 12,184 | 11,653 |
Long-term debt | 33,222 | 32,895 |
Long-term tax liabilities | 6,594 | 6,968 |
Other noncurrent liabilities | 2,465 | 2,023 |
Contingencies and commitments | ||
Stockholders equity: | ||
Common stock and additional paid-in capital; $0.0001 par value per share; 2,750.0 shares authorized; outstanding558.3 shares in 2021 and 578.3 shares in 2020 | 32,096 | 31,802 |
Accumulated deficit | (24,600) | (21,408) |
Accumulated other comprehensive loss | (796) | (985) |
Total stockholders equity | 6,700 | 9,409 |
Total liabilities and stockholders equity | 61,165 | 62,948 |
External Links | |
AMGEN INC (AMGN) Fiscal Year 2021 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |